05Aug
Defying gravity: US M&A H1 2019: Pharma chases innovation through deals
The need to replenish intellectual property has pushed the pharma industry to the highest-performing sector by M&A value. In the pharmaceuticals, medical and biotech sector, deal value in the first half of the year was up 142 percent to US$172...
By:
White & Case LLP
Related
On July 25, 2019, New York Governor Anthony Cuomo signed the Stop Hacks and Improve Electronic Data ...
Read More >
In Lee v. Argent Trust Co., the court dismissed ERISA claims challenging an ESOP stock transaction b...
Read More >
New Jersey amended its existing WARN Act, otherwise known as the Millville Dallas Airmotive Plant Jo...
Read More >
On October 13, 2019, New York City enacted Int. 136-A (“Law”), which will extend the employment pr...
Read More >
Wage and Hour - 80/20 Rule Still Followed in Some Parts - The U.S. Department of Labor (DOL) iss...
Read More >
A new change to California’s Civil Discovery Act has all of the trappings of a burdensome and costl...
Read More >